Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Douglas S. Ingram files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
- Thomas Catinazzo - $5.49M in RLAY purchases and sales in the last 12 months
- Sanjiv Patel - $4.48M in RLAY purchases and sales in the last 12 months
- Donald A. Bergstrom - $2.34M in RLAY purchases and sales in the last 12 months
- Peter Rahmer - $1.46M in RLAY purchases and sales in the last 12 months
- Ian Michael Estepan - $294K in SRPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Douglas S. Ingram?
Douglas S. Ingram is a corporate insider of Relay Therapeutics, Inc. (RLAY). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Douglas S. Ingram last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 3 filings going back to 2025.
